Semanteon Capital Management LP Increases Stock Holdings in National Research Co. (NASDAQ:NRC)

Semanteon Capital Management LP lifted its stake in National Research Co. (NASDAQ:NRC) by 9.9% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 10,281 shares of the company’s stock after purchasing an additional 929 shares during the quarter. Semanteon Capital Management LP’s holdings in National Research were worth $181,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of NRC. Hotchkis & Wiley Capital Management LLC purchased a new position in shares of National Research in the 3rd quarter worth approximately $3,158,000. Bank of New York Mellon Corp boosted its holdings in shares of National Research by 88.5% in the 4th quarter. Bank of New York Mellon Corp now owns 217,212 shares of the company’s stock worth $3,832,000 after purchasing an additional 101,957 shares during the period. Algert Global LLC boosted its holdings in shares of National Research by 94.0% in the 3rd quarter. Algert Global LLC now owns 82,921 shares of the company’s stock worth $1,896,000 after purchasing an additional 40,182 shares during the period. Barclays PLC boosted its holdings in shares of National Research by 65.6% in the 3rd quarter. Barclays PLC now owns 51,331 shares of the company’s stock worth $1,175,000 after purchasing an additional 20,331 shares during the period. Finally, Proficio Capital Partners LLC purchased a new position in shares of National Research in the 4th quarter worth approximately $283,000. Hedge funds and other institutional investors own 47.26% of the company’s stock.

National Research Price Performance

Shares of National Research stock opened at $14.44 on Friday. The stock has a market cap of $338.99 million, a price-to-earnings ratio of 13.75 and a beta of 0.47. The company has a debt-to-equity ratio of 1.30, a quick ratio of 0.47 and a current ratio of 0.47. The stock has a 50 day moving average price of $16.24 and a 200-day moving average price of $18.31. National Research Co. has a one year low of $13.74 and a one year high of $40.14.

National Research (NASDAQ:NRC) last issued its quarterly earnings results on Monday, January 27th. The company reported $0.28 earnings per share (EPS) for the quarter. National Research had a return on equity of 66.52% and a net margin of 17.32%.

About National Research

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.